{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:01:43Z","timestamp":1787583703160,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["117S440"],"award-info":[{"award-number":["117S440"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["117S440"],"award-info":[{"award-number":["117S440"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["117S440"],"award-info":[{"award-number":["117S440"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98680-y","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:59:26Z","timestamp":1751381966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Investigating hepatic fibrosis heterogeneity by three-dimensional imaging in metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Buket","family":"Yigit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekin","family":"Ozgonul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Yaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Sipahioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burge","family":"Ulukan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagmur","family":"Cetin Tas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berna","family":"Morova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigit","family":"Uysalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Demirtas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mert","family":"Erkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurkan","family":"Tellioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dila","family":"Atak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Gursoy Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sercin","family":"Karahuseyinoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Yurdaydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Akyildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guruprasad Padur","family":"Aithal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hale","family":"Kirimlioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Dayangac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Ferhanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Kiraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcjdat","family":"Zeybel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"98680_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.32285","volume":"75","author":"SL Friedman","year":"2022","unstructured":"Friedman, S. L. & Pinzani, M. Hepatic fibrosis 2022: Unmet needs and a blueprint for the future. Hepatology 75, 473\u2013488. https:\/\/doi.org\/10.1002\/hep.32285 (2022).","journal-title":"Hepatology"},{"key":"98680_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"98680_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/s2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7, 851\u2013861. https:\/\/doi.org\/10.1016\/s2468-1253(22)00165-0 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"98680_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo, P. et al. Liver fibrosis, but no other histologic features, is associated with Long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149, 389\u2013397e310. https:\/\/doi.org\/10.1053\/j.gastro.2015.04.043 (2015).","journal-title":"Gastroenterology"},{"key":"98680_CR5","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt, M. et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 61, 1547\u20131554. https:\/\/doi.org\/10.1002\/hep.27368 (2015).","journal-title":"Hepatology"},{"key":"98680_CR6","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.cgh.2022.06.029","volume":"21","author":"A Tang","year":"2023","unstructured":"Tang, A. et al. Comparative burden of metabolic dysfunction in lean NAFLD vs Non-lean NAFLD\u2014A systematic review and Meta-analysis. Clin. Gastroenterol. Hepatol. 21, 1750\u20131760e1712. https:\/\/doi.org\/10.1016\/j.cgh.2022.06.029 (2023).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"98680_CR7","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1038\/s41591-024-03284-0","volume":"30","author":"O Jamialahmadi","year":"2024","unstructured":"Jamialahmadi, O. et al. Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease. Nat. Med. 30, 3614\u20133623. https:\/\/doi.org\/10.1038\/s41591-024-03284-0 (2024).","journal-title":"Nat. Med."},{"key":"98680_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/gut.2005.084475","volume":"55","author":"RA Standish","year":"2006","unstructured":"Standish, R. A., Cholongitas, E., Dhillon, A., Burroughs, A. K. & Dhillon, A. P. An appraisal of the histopathological assessment of liver fibrosis. Gut 55, 569\u2013578. https:\/\/doi.org\/10.1136\/gut.2005.084475 (2006).","journal-title":"Gut"},{"key":"98680_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/hep.27173","volume":"60","author":"P Bedossa","year":"2014","unstructured":"Bedossa, P. Utility and appropriateness of the fatty liver Inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. Hepatology 60, 565\u2013575. https:\/\/doi.org\/10.1002\/hep.27173 (2014).","journal-title":"Hepatology"},{"key":"98680_CR10","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.jhep.2020.06.025","volume":"73","author":"BA Davison","year":"2020","unstructured":"Davison, B. A. et al. Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials. J. Hepatol. 73, 1322\u20131332. https:\/\/doi.org\/10.1016\/j.jhep.2020.06.025 (2020).","journal-title":"J. Hepatol."},{"key":"98680_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hep.1840200104","volume":"20","author":"The French METAVIR Cooperative Study Group","year":"1994","unstructured":"The French METAVIR Cooperative Study Group. Intraobserver Interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20, 15\u201320 (1994).","journal-title":"Hepatology"},{"key":"98680_CR12","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","volume":"128","author":"V Ratziu","year":"2005","unstructured":"Ratziu, V. et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128, 1898\u20131906. https:\/\/doi.org\/10.1053\/j.gastro.2005.03.084 (2005).","journal-title":"Gastroenterology"},{"key":"98680_CR13","doi-asserted-by":"publisher","unstructured":"Ratziu, V. & Friedman, S. L. Why do so many nonalcoholic steatohepatitis trials fail? Gastroenterology 165, 5\u201310. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.046 (2023).","DOI":"10.1053\/j.gastro.2020.05.046"},{"key":"98680_CR14","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/hep.22745","volume":"49","author":"V Calvaruso","year":"2009","unstructured":"Calvaruso, V. et al. Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient. Hepatology 49, 1236\u20131244. https:\/\/doi.org\/10.1002\/hep.22745 (2009).","journal-title":"Hepatology"},{"key":"98680_CR15","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/apt.15219","volume":"49","author":"E Buzzetti","year":"2019","unstructured":"Buzzetti, E. et al. Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 49, 1214\u20131222. https:\/\/doi.org\/10.1111\/apt.15219 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"98680_CR16","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jhep.2013.12.023","volume":"60","author":"E Tsochatzis","year":"2014","unstructured":"Tsochatzis, E. et al. Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis. J. Hepatol. 60, 948\u2013954. https:\/\/doi.org\/10.1016\/j.jhep.2013.12.023 (2014).","journal-title":"J. Hepatol."},{"key":"98680_CR17","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jhep.2009.12.009","volume":"52","author":"L Gailhouste","year":"2010","unstructured":"Gailhouste, L. et al. Fibrillar collagen scoring by second harmonic microscopy: A new tool in the assessment of liver fibrosis. J. Hepatol. 52, 398\u2013406. https:\/\/doi.org\/10.1016\/j.jhep.2009.12.009 (2010).","journal-title":"J. Hepatol."},{"key":"98680_CR18","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1136\/gutjnl-2019-318841","volume":"69","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Quantifying and monitoring fibrosis in non-alcoholic fatty liver disease using dual-photon microscopy. Gut 69, 1116\u20131126. https:\/\/doi.org\/10.1136\/gutjnl-2019-318841 (2020).","journal-title":"Gut"},{"key":"98680_CR19","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/s41591-019-0660-7","volume":"25","author":"F Segovia-Miranda","year":"2019","unstructured":"Segovia-Miranda, F. et al. Three-dimensional spatially resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression. Nat. Med. 25, 1885\u20131893. https:\/\/doi.org\/10.1038\/s41591-019-0660-7 (2019).","journal-title":"Nat. Med."},{"key":"98680_CR20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.cell.2015.06.067","volume":"162","author":"DS Richardson","year":"2015","unstructured":"Richardson, D. S. & Lichtman, J. W. Clarifying tissue clearing. Cell 162, 246\u2013257. https:\/\/doi.org\/10.1016\/j.cell.2015.06.067 (2015).","journal-title":"Cell"},{"key":"98680_CR21","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nmeth.2481","volume":"10","author":"K Chung","year":"2013","unstructured":"Chung, K. & Deisseroth, K. CLARITY for mapping the nervous system. Nat. Methods. 10, 508\u2013513. https:\/\/doi.org\/10.1038\/nmeth.2481 (2013).","journal-title":"Nat. Methods"},{"key":"98680_CR22","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1038\/nprot.2012.119","volume":"7","author":"A Ert\u00fcrk","year":"2012","unstructured":"Ert\u00fcrk, A. et al. Three-dimensional imaging of solvent-cleared organs using 3DISCO. Nat. Protoc. 7, 1983\u20131995. https:\/\/doi.org\/10.1038\/nprot.2012.119 (2012).","journal-title":"Nat. Protoc."},{"key":"98680_CR23","doi-asserted-by":"publisher","first-page":"9269","DOI":"10.1038\/s41598-017-09117-0","volume":"7","author":"S Nojima","year":"2017","unstructured":"Nojima, S. et al. CUBIC pathology: Three-dimensional imaging for pathological diagnosis. Sci. Rep. 7, 9269. https:\/\/doi.org\/10.1038\/s41598-017-09117-0 (2017).","journal-title":"Sci. Rep."},{"key":"98680_CR24","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1038\/nprot.2014.123","volume":"9","author":"R Tomer","year":"2014","unstructured":"Tomer, R., Ye, L., Hsueh, B. & Deisseroth, K. Advanced CLARITY for rapid and high-resolution imaging of intact tissues. Nat. Protoc. 9, 1682\u20131697. https:\/\/doi.org\/10.1038\/nprot.2014.123 (2014).","journal-title":"Nat. Protoc."},{"key":"98680_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14744\/hf.2023.2023.0011","volume":"4","author":"Y Yilmaz","year":"2023","unstructured":"Yilmaz, Y. et al. TASL practice guidance on the clinical assessment and management of patients with nonalcoholic fatty liver disease. Hepatol. Forum 4, 1\u201332. https:\/\/doi.org\/10.14744\/hf.2023.2023.0011 (2023).","journal-title":"Hepatol. Forum"},{"key":"98680_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.14744\/hf.2023.2023.0044","volume":"4","author":"Y Yilmaz","year":"2023","unstructured":"Yilmaz, Y. The heated debate over NAFLD renaming: An ongoing saga. Hepatol. Forum 4, 89\u201391. https:\/\/doi.org\/10.14744\/hf.2023.2023.0044 (2023).","journal-title":"Hepatol. Forum"},{"key":"98680_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/hep.32302","volume":"76","author":"N Kawamura","year":"2022","unstructured":"Kawamura, N. et al. Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 76, 186\u2013195. https:\/\/doi.org\/10.1002\/hep.32302 (2022).","journal-title":"Hepatology"},{"key":"98680_CR28","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s00330-019-06478-0","volume":"30","author":"R Rezvani Habibabadi","year":"2020","unstructured":"Rezvani Habibabadi, R. et al. Comparison between ROI-based and volumetric measurements in quantifying heterogeneity of liver stiffness using MR elastography. Eur. Radiol. 30, 1609\u20131615. https:\/\/doi.org\/10.1007\/s00330-019-06478-0 (2020).","journal-title":"Eur. Radiol."},{"key":"98680_CR29","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/hep.30664","volume":"70","author":"AJ Sanyal","year":"2019","unstructured":"Sanyal, A. J. et al. The natural history of advanced fibrosis due to nonalcoholic steatohepatitis: data from the Simtuzumab trials. Hepatology 70, 1913\u20131927. https:\/\/doi.org\/10.1002\/hep.30664 (2019).","journal-title":"Hepatology"},{"key":"98680_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1365-2036.2004.01882.x","volume":"19","author":"AH Malik","year":"2004","unstructured":"Malik, A. H. et al. Correlation of percutaneous liver biopsy fragmentation with the degree of fibrosis. Aliment. Pharmacol. Ther. 19, 545\u2013549. https:\/\/doi.org\/10.1111\/j.1365-2036.2004.01882.x (2004).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"98680_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-017-0084","author":"AK Glaser","year":"2017","unstructured":"Glaser, A. K. et al. Light-sheet microscopy for slide-free non-destructive pathology of large clinical specimens. Nat. Biomed. Eng. https:\/\/doi.org\/10.1038\/s41551-017-0084 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"98680_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41551-020-00681-x","volume":"5","author":"JTC Liu","year":"2021","unstructured":"Liu, J. T. C. et al. Harnessing non-destructive 3D pathology. Nat. Biomed. Eng. 5, 203\u2013218. https:\/\/doi.org\/10.1038\/s41551-020-00681-x (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"98680_CR33","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41551-017-0139-0","volume":"1","author":"N Tanaka","year":"2017","unstructured":"Tanaka, N. et al. Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity. Nat. Biomed. Eng. 1, 796\u2013806. https:\/\/doi.org\/10.1038\/s41551-017-0139-0 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"98680_CR34","doi-asserted-by":"publisher","first-page":"e0233198","DOI":"10.1371\/journal.pone.0233198","volume":"15","author":"R Serafin","year":"2020","unstructured":"Serafin, R., Xie, W., Glaser, A. K. & Liu, J. T. C. FalseColor-Python: A rapid intensity-leveling and digital-staining package for fluorescence-based slide-free digital pathology. PLoS One. 15, e0233198. https:\/\/doi.org\/10.1371\/journal.pone.0233198 (2020).","journal-title":"PLoS One"},{"key":"98680_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","volume":"69","author":"T Tsuchida","year":"2018","unstructured":"Tsuchida, T. et al. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. J. Hepatol. 69, 385\u2013395. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.011 (2018).","journal-title":"J. Hepatol."},{"key":"98680_CR36","doi-asserted-by":"publisher","first-page":"G987","DOI":"10.1152\/ajpgi.90272.2008","volume":"295","author":"LH Tetri","year":"2008","unstructured":"Tetri, L. H., Basaranoglu, M., Brunt, E. M., Yerian, L. M. & Neuschwander-Tetri, B. A. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G987\u2013995. https:\/\/doi.org\/10.1152\/ajpgi.90272.2008 (2008).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"98680_CR37","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nmeth.2507","volume":"10","author":"PG Pitrone","year":"2013","unstructured":"Pitrone, P. G. et al. OpenSPIM: An open-access light-sheet microscopy platform. Nat. Methods 10, 598\u2013599. https:\/\/doi.org\/10.1038\/nmeth.2507 (2013).","journal-title":"Nat. Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98680-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98680-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98680-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:59:26Z","timestamp":1751381966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98680-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98680"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98680-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20736"}}